Classification and prediction of toxicity of chemicals using an automated phenotypic profiling of Caenorhabditis elegans

Abstract

BackgroundTraditional toxicological studies have relied heavily on various animal models to understand the effect of various compounds in a biological context. Considering the great cost, complexity and time involved in experiments using higher order organisms. Researchers have been exploring alternative models that avoid these disadvantages. One example of such a model is the nematode Caenorhabditis elegans. There are some advantages of C. elegans, such as small size, short life cycle, well defined genome, ease of maintenance and efficient reproduction.MethodsAs these benefits allow large scale studies to be initiated with relative ease, the problem of how to efficiently capture, organize and analyze the resulting large volumes of data must be addressed. We have developed a new method for quantitative screening of chemicals using C. elegans. 33 features were identified for each chemical treatment.ResultsThe compounds with different toxicities were shown to alter the phenotypes of C. elegans in distinct and detectable patterns. We found that phenotypic profiling revealed conserved functions to classify and predict the toxicity of different chemicals.ConclusionsOur results demonstrate the power of phenotypic profiling in C. elegans under different chemical environments.Electronic supplementary materialThe online version of this article (10.1186/s40360-018-0208-3) contains supplementary material, which is available to authorized users.

Caenorhabditis elegans Neurotoxicity Testing: Novel Applications in the Adverse Outcome Pathway Framework

“…In this direction we have demonstrated three behavioral assays for the assessment of dopaminergic and cholinergic function and two assays for the ascertaining neurodegeneration in cholinergic and dopaminergic neurons. While the main focus of this article is on neurotoxicological assessment, C. elegans is also an established model to study toxicity ( Hunt, 2017 ; Xiong et al, 2017 ; Gao et al, 2018 ) which can also be compared with neurotoxicological findings. The above assays rely on conserved nature of biochemical pathways, genes and neurotransmitters.…”

A Multimodal Genotoxic Anticancer Drug Characterized by Pharmacogenetic Analysis in Caenorhabditis elegans

“…Furthermore, the cytochrome P450-based metabolic capabilities of C. elegans are broadly similar to those of mammals (Harlow et al 2018). For these reasons, C. elegans has been used as an in vivo model system to predict the effect of chemicals on mammalian development (Harlow et al 2016), germline function (Allard et al 2013;Shin et al 2019), mutagenicity (Meier et al 2014), and toxicity (Gao et al 2018). We have used a complementary suite of mutagenicity, mutational profiles, and genotypic sensitivity assays that utilize C. elegans to characterize the new anticancer chemotherapeutic CX-5461.…”

High‐throughput COPAS assay for screening of developmental and reproductive toxicity of nanoparticles using the nematode Caenorhabditis elegans

“…In recent years, the incorporation of COPAS assays has been attempted in toxicological screening studies (Pulak, ). The results of these studies showed that COPAS is a suitable and reliable system for assaying the changes in mitochondrial morphology and activity (Daniele et al, ; Hunt, Olejnik, Bailey, Vaught, & Sprando, ), heavy metal toxicity (Hunt, Olejnik, & Sprando, ), toxicity assessment of neurotoxicants (Boyd, et al, ), and environmental toxicants (Boyd, McBride, Rice, Snyder, & Freedman, (), and enables the screening of drug libraries (Cho, Behnam Azad, Luyt, & Lewis, ), metal NMs (Jeong et al, ; Kim et al, ) and phenotype profiling of C. elegans in different chemical environments (Gao et al, ). However, COPAS has several limitations.…”